mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-06 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
1e-06 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-06 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-06 |
mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
4e-06 |
mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
4e-06 |